AstraZeneca to buy EsoBiotec for up to $1 billion Deal aims to enhance cancer cell therapy capabilities AstraZeneca secures global rights to Alteogen's ALT-B4 enzyme AstraZeneca shares up almost ...
Pharmaceutical giant AstraZeneca has admitted that its widely used Covid vaccine, branded Covishield, can cause rare side effects including blood clots and low platelet count. Covishield was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback